A pilot study of the CMV inSIGHT T-cell immunity panel to assess cytomegalovirus (CMV) cell mediated immunity (CMI) in allogeneic hematopoietic cell transplant (HCT) recipients.

Prevymis (letermovir) - Merck (MSD)

cyclophosphamide - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/42241896

Brian Shaffer; Evangelos Ntrivalas; Genovefa A Papanicolaou; Gyuri Han; Isabelle Ulloa; Jalal Siddiqui; Miguel Angel Perales; Rich Kodama; Steve Kleiboeker; Swarn Arya; Yuxuan Li

Jun 5, 2026